Skandinaviska Enskilda Banken (SEB)’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-18,000	Closed	-$1.29M	–	877
2023 Q4	$1.29M	Hold	18,000	–	–	0.01%	656
2023 Q3	$1.08M	Buy	18,000 +1,400	+8%	+$83.9K	0.01%	671
2023 Q2	$1.2M	Sell	16,600 -6,000	-27%	-$433K	0.01%	673
2023 Q1	$1.66M	Buy	+22,600	New	+$1.66M	0.01%	591